BioMarin reports Q3 revenue growth, but posts a net loss due to higher R&D spending and an acquired IPR&D charge.
NFL fines Ravens $100K for incorrectly listing Lamar Jackson's practice status, renewing debate on injury reporting transparency.
Validea analyzes ten U.S. stocks against guru investment strategies, providing model-specific scores that reflect each firm's fundamentals and valuation.
BioMarin reports Q3 revenue growth, but posts a net loss due to higher R&D spending and an acquired IPR&D charge.
NFL fines Ravens $100K for incorrectly listing Lamar Jackson's practice status, renewing debate on injury reporting transparency.
Validea analyzes ten U.S. stocks against guru investment strategies, providing model-specific scores that reflect each firm's fundamentals and valuation.